BEIJING, March 26, 2021 /PRNewswire/ — InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2020 annual results
Tag: InnoCare
InnoCare Appoints Dr. Sean Zhang as Main Clinical Officer | Organization & Finance
BEIJING–(Company WIRE)–Feb 28, 2021– InnoCare Pharma (HKEX: 09969), a top biopharmaceutical firm concentrating on most cancers and autoimmune ailments, announced these days that the Organization